VIR R&D to Revenue
Vir Biotechnology Inc · R&D to Revenue
VIR R&D to Revenue
Latest reported54.97%period ending
VIR Quarterly R&D/Revenue (1039.70% → 54.97%)
Latest values, visible window
High-resolution chart · PNG
VIR r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 54.971% | |
| -368,968.9655% | |
| 133.4962% | |
| 61,627.0833% | |
| 6,969.687% | |
| 3,784.5646% | |
| 659.9079% | |
| 7,971.0924% | |
| 3,182.5366% | |
| 166.6649% | |
| 533.3651% | |
| 5,443.9939% | |
| 4,401.1588% | |
| 205.5451% | |
| 310.0992% | |
| 30.0312% | |
| -279.3227% | |
| 7.195% | |
| 15.6039% | |
| 93.1931% | |
| 48.2826% | |
| 6,754.4534% | |
| 4,945.5594% | |
| 3,550.4149% | |
| 115.5685% | |
| 999.5978% | |
| 4,908.7755% | |
| 2,721.8817% | |
| 1,402.0029% | |
| 678.3119% | |
| 674.1843% | |
| 1,009.74% | |
| 1,039.7037% | |
| 1,039.7037% |